The question is sam how do we move forward in this climate of uncertainty, where are the 20-30 million funding coming from to move this forward to phase IIb
It looks like we have a drug in ATl1102 DMD but do they have the skills and contacts (management diamond/goob)to bring this drug all the way through to market approval??
on past performances im not so sure!
After all these broken promises we are still hanging on
hope its different this time round
glta
ANP Price at posting:
4.8¢ Sentiment: Hold Disclosure: Held
